Robert Marc Schainfeld, D.O.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arterial Occlusive Diseases | 11 | 2015 | 793 | 1.580 |
Why?
|
| Angioplasty, Balloon | 11 | 2017 | 653 | 1.110 |
Why?
|
| Stents | 19 | 2020 | 3282 | 1.020 |
Why?
|
| Popliteal Artery | 5 | 2015 | 317 | 1.020 |
Why?
|
| Thrombectomy | 5 | 2014 | 680 | 0.990 |
Why?
|
| Peripheral Vascular Diseases | 10 | 2006 | 550 | 0.970 |
Why?
|
| Ultrasonography, Doppler, Duplex | 9 | 2019 | 205 | 0.950 |
Why?
|
| Venous Thrombosis | 8 | 2020 | 1239 | 0.940 |
Why?
|
| Femoral Artery | 7 | 2015 | 845 | 0.910 |
Why?
|
| Catheterization, Peripheral | 5 | 2020 | 345 | 0.800 |
Why?
|
| Thrombolytic Therapy | 7 | 2020 | 2162 | 0.750 |
Why?
|
| Vena Cava, Superior | 2 | 2020 | 193 | 0.740 |
Why?
|
| Ischemia | 11 | 2018 | 1907 | 0.640 |
Why?
|
| Fibrinolytic Agents | 5 | 2020 | 2158 | 0.630 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2017 | 549 | 0.620 |
Why?
|
| Vena Cava Filters | 2 | 2012 | 253 | 0.600 |
Why?
|
| Ultrasonography, Interventional | 8 | 2013 | 1486 | 0.570 |
Why?
|
| Vertebrobasilar Insufficiency | 2 | 2008 | 114 | 0.540 |
Why?
|
| Aneurysm, False | 2 | 2017 | 276 | 0.480 |
Why?
|
| Celiac Artery | 2 | 2017 | 69 | 0.440 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2013 | 60 | 0.440 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2020 | 53 | 0.440 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2017 | 101 | 0.430 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 934 | 0.420 |
Why?
|
| Vena Cava, Inferior | 2 | 2012 | 440 | 0.400 |
Why?
|
| Endovascular Procedures | 3 | 2020 | 1980 | 0.380 |
Why?
|
| Microdissection | 2 | 2009 | 152 | 0.370 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 222 | 0.370 |
Why?
|
| Thrombin | 1 | 2013 | 598 | 0.370 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2017 | 277 | 0.360 |
Why?
|
| Subclavian Steal Syndrome | 2 | 2008 | 23 | 0.350 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 547 | 0.350 |
Why?
|
| Vascular System Injuries | 1 | 2012 | 250 | 0.330 |
Why?
|
| Renal Artery Obstruction | 3 | 2009 | 248 | 0.330 |
Why?
|
| Brachiocephalic Trunk | 1 | 2008 | 44 | 0.320 |
Why?
|
| Axillary Vein | 2 | 2008 | 16 | 0.320 |
Why?
|
| Device Removal | 2 | 2012 | 656 | 0.310 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2006 | 1391 | 0.310 |
Why?
|
| Vascular Patency | 7 | 2017 | 887 | 0.310 |
Why?
|
| Vascular Surgical Procedures | 3 | 2014 | 1476 | 0.300 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 1206 | 0.290 |
Why?
|
| Leg | 9 | 2006 | 1116 | 0.280 |
Why?
|
| Atherectomy | 2 | 2006 | 47 | 0.280 |
Why?
|
| Embolism | 2 | 2009 | 408 | 0.280 |
Why?
|
| Embolism, Cholesterol | 1 | 2006 | 34 | 0.280 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 1084 | 0.280 |
Why?
|
| Angiography | 4 | 2006 | 1639 | 0.260 |
Why?
|
| Radial Artery | 2 | 2017 | 194 | 0.260 |
Why?
|
| Thoracic Wall | 1 | 2007 | 203 | 0.260 |
Why?
|
| Arm | 1 | 2008 | 589 | 0.250 |
Why?
|
| Popliteal Vein | 2 | 2014 | 43 | 0.240 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2004 | 40 | 0.230 |
Why?
|
| Intermittent Claudication | 3 | 2006 | 309 | 0.230 |
Why?
|
| Peripheral Arterial Disease | 3 | 2023 | 1188 | 0.230 |
Why?
|
| Subclavian Vein | 1 | 2003 | 54 | 0.230 |
Why?
|
| Carotid Artery, Common | 1 | 2004 | 183 | 0.220 |
Why?
|
| Upper Extremity | 2 | 2018 | 648 | 0.220 |
Why?
|
| Iliac Vein | 3 | 2014 | 72 | 0.210 |
Why?
|
| Aortic Diseases | 1 | 2008 | 743 | 0.210 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 2375 | 0.210 |
Why?
|
| Iliac Artery | 1 | 2003 | 364 | 0.200 |
Why?
|
| Lower Extremity | 3 | 2018 | 1158 | 0.200 |
Why?
|
| Saphenous Vein | 1 | 2005 | 532 | 0.200 |
Why?
|
| Sirolimus | 2 | 2009 | 1565 | 0.200 |
Why?
|
| Catheterization | 5 | 2014 | 1470 | 0.200 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2008 | 1261 | 0.200 |
Why?
|
| Treatment Outcome | 24 | 2022 | 63107 | 0.190 |
Why?
|
| Aorta, Abdominal | 1 | 2003 | 646 | 0.190 |
Why?
|
| Renal Artery | 1 | 2022 | 399 | 0.180 |
Why?
|
| Anticoagulants | 7 | 2020 | 4600 | 0.180 |
Why?
|
| Constriction, Pathologic | 5 | 2009 | 1107 | 0.180 |
Why?
|
| Brachytherapy | 2 | 2005 | 1248 | 0.180 |
Why?
|
| Calcinosis | 1 | 2008 | 1499 | 0.180 |
Why?
|
| Carotid Stenosis | 4 | 2009 | 854 | 0.170 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 834 | 0.160 |
Why?
|
| Foramen Ovale, Patent | 2 | 2013 | 223 | 0.160 |
Why?
|
| Pulmonary Edema | 1 | 2001 | 414 | 0.160 |
Why?
|
| Amphetamines | 1 | 2018 | 148 | 0.150 |
Why?
|
| Brachial Artery | 2 | 2017 | 369 | 0.140 |
Why?
|
| Arteries | 1 | 2001 | 1119 | 0.140 |
Why?
|
| Endothelial Growth Factors | 5 | 2001 | 694 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2002 | 1125 | 0.140 |
Why?
|
| Humans | 61 | 2023 | 744366 | 0.130 |
Why?
|
| Vasoconstriction | 1 | 2018 | 597 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2009 | 3444 | 0.130 |
Why?
|
| Catheters, Indwelling | 2 | 2008 | 426 | 0.130 |
Why?
|
| Renal Dialysis | 4 | 2017 | 1783 | 0.120 |
Why?
|
| Gene Transfer Techniques | 5 | 2001 | 1225 | 0.120 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 855 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2005 | 2921 | 0.120 |
Why?
|
| Radiography | 6 | 2013 | 7023 | 0.120 |
Why?
|
| Femoral Vein | 1 | 2014 | 159 | 0.110 |
Why?
|
| Phlebography | 3 | 2009 | 333 | 0.110 |
Why?
|
| Carotid Arteries | 2 | 2009 | 950 | 0.110 |
Why?
|
| Lymphokines | 4 | 2001 | 949 | 0.110 |
Why?
|
| Veins | 1 | 2017 | 770 | 0.110 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 154 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 4153 | 0.100 |
Why?
|
| Aneurysm | 1 | 2014 | 339 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 659 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 2073 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 4459 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 1148 | 0.090 |
Why?
|
| Equipment Design | 3 | 2009 | 3582 | 0.090 |
Why?
|
| Hypertension, Renovascular | 1 | 2009 | 123 | 0.090 |
Why?
|
| Male | 31 | 2022 | 350115 | 0.080 |
Why?
|
| Risk Factors | 14 | 2023 | 72296 | 0.080 |
Why?
|
| Time Factors | 11 | 2020 | 40075 | 0.080 |
Why?
|
| Thrombophlebitis | 1 | 2009 | 309 | 0.080 |
Why?
|
| Stockings, Compression | 1 | 2008 | 37 | 0.080 |
Why?
|
| Salmonella Infections | 1 | 2009 | 173 | 0.080 |
Why?
|
| Aortography | 1 | 2008 | 437 | 0.070 |
Why?
|
| Axillary Artery | 1 | 2006 | 50 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 15535 | 0.070 |
Why?
|
| Dizziness | 1 | 2008 | 251 | 0.070 |
Why?
|
| Beta Particles | 1 | 2005 | 50 | 0.060 |
Why?
|
| Pelvis | 1 | 2009 | 730 | 0.060 |
Why?
|
| Music | 1 | 2008 | 263 | 0.060 |
Why?
|
| Tibial Arteries | 1 | 2005 | 57 | 0.060 |
Why?
|
| Female | 28 | 2020 | 380193 | 0.060 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2006 | 482 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1620 | 0.060 |
Why?
|
| Middle Aged | 23 | 2019 | 213390 | 0.060 |
Why?
|
| Recurrence | 8 | 2014 | 8340 | 0.060 |
Why?
|
| Limb Salvage | 2 | 2018 | 433 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 850 | 0.060 |
Why?
|
| Probucol | 1 | 2002 | 23 | 0.050 |
Why?
|
| Drug-Eluting Stents | 1 | 2009 | 753 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 641 | 0.050 |
Why?
|
| Retrospective Studies | 12 | 2022 | 77460 | 0.050 |
Why?
|
| Radiography, Interventional | 2 | 2009 | 1095 | 0.050 |
Why?
|
| Knee Prosthesis | 1 | 2006 | 425 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 3508 | 0.050 |
Why?
|
| Time | 1 | 2003 | 542 | 0.050 |
Why?
|
| Aged | 20 | 2020 | 163288 | 0.050 |
Why?
|
| MEDLINE | 1 | 2001 | 125 | 0.050 |
Why?
|
| Patient Selection | 3 | 2013 | 4216 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 12961 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2005 | 355 | 0.050 |
Why?
|
| Hypertension | 1 | 2001 | 8479 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 633 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2002 | 339 | 0.050 |
Why?
|
| Ultrasonics | 1 | 2001 | 212 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1092 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 1771 | 0.040 |
Why?
|
| Postthrombotic Syndrome | 1 | 2019 | 28 | 0.040 |
Why?
|
| Stem Cells | 1 | 2012 | 3567 | 0.040 |
Why?
|
| Thromboangiitis Obliterans | 1 | 1998 | 10 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 1392 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2002 | 3070 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8642 | 0.040 |
Why?
|
| Hospitals, General | 2 | 2013 | 749 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6539 | 0.040 |
Why?
|
| Thrombosis | 2 | 2017 | 2968 | 0.040 |
Why?
|
| Vasodilation | 1 | 2002 | 944 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 976 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2001 | 772 | 0.040 |
Why?
|
| Boston | 3 | 2017 | 9312 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 3 | 2005 | 1351 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2001 | 604 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2002 | 835 | 0.040 |
Why?
|
| DNA | 2 | 2001 | 7294 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2002 | 899 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2005 | 7282 | 0.030 |
Why?
|
| Muscles | 1 | 2001 | 1614 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 1660 | 0.030 |
Why?
|
| Injections, Intramuscular | 2 | 2012 | 552 | 0.030 |
Why?
|
| Edema | 1 | 2000 | 789 | 0.030 |
Why?
|
| Extremities | 1 | 2001 | 866 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 9145 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2020 | 2274 | 0.030 |
Why?
|
| Venous Insufficiency | 1 | 1996 | 103 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2000 | 1730 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2535 | 0.030 |
Why?
|
| Recovery of Function | 2 | 2017 | 2926 | 0.030 |
Why?
|
| Sepsis | 1 | 2009 | 2593 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1996 | 599 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2020 | 7730 | 0.030 |
Why?
|
| Embolism, Paradoxical | 1 | 2013 | 58 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 57776 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 128 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10388 | 0.030 |
Why?
|
| Adult | 9 | 2019 | 214052 | 0.030 |
Why?
|
| Hematoma | 1 | 2017 | 758 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2219 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1997 | 1504 | 0.020 |
Why?
|
| Stroke | 2 | 2013 | 9981 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15078 | 0.020 |
Why?
|
| Plasmids | 3 | 2001 | 2308 | 0.020 |
Why?
|
| Life Style | 1 | 2001 | 3835 | 0.020 |
Why?
|
| Ultrasonography | 3 | 2017 | 5984 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 2009 | 1423 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1997 | 1873 | 0.020 |
Why?
|
| Age Factors | 2 | 2020 | 18373 | 0.020 |
Why?
|
| Inpatients | 1 | 2020 | 2518 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2020 | 23336 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2001 | 3511 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2013 | 935 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2124 | 0.020 |
Why?
|
| Collateral Circulation | 2 | 2000 | 287 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1993 | 1572 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1530 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 458 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 2 | 1998 | 341 | 0.020 |
Why?
|
| Thrombophilia | 1 | 2009 | 305 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1525 | 0.020 |
Why?
|
| Alloys | 1 | 2006 | 122 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 233 | 0.020 |
Why?
|
| Exercise | 1 | 2001 | 5615 | 0.020 |
Why?
|
| Quality of Life | 2 | 2019 | 12802 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9849 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2009 | 4196 | 0.020 |
Why?
|
| Prevalence | 1 | 2001 | 15221 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 6486 | 0.010 |
Why?
|
| Kidney | 2 | 2009 | 7184 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6366 | 0.010 |
Why?
|
| Prognosis | 3 | 2013 | 29060 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2009 | 2297 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2460 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12356 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6896 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 2004 | 445 | 0.010 |
Why?
|
| Ankle | 1 | 2005 | 327 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3528 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1993 | 3107 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2785 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 2013 | 1620 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 11726 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2008 | 831 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3873 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3508 | 0.010 |
Why?
|
| Critical Illness | 1 | 2012 | 2670 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2005 | 1011 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5300 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2006 | 2110 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12025 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1993 | 6077 | 0.010 |
Why?
|
| Diuretics | 1 | 2000 | 591 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 39052 | 0.010 |
Why?
|
| Cause of Death | 1 | 2005 | 3582 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14723 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 1799 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 1185 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 13882 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2012 | 53290 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 1997 | 924 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2000 | 3914 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56429 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15297 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1998 | 1443 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7182 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 20952 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1461 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 168768 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4569 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1996 | 4222 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 4925 | 0.000 |
Why?
|
| Coronary Angiography | 1 | 1997 | 4576 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11718 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1993 | 5077 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20130 | 0.000 |
Why?
|
| Apoptosis | 1 | 1997 | 9724 | 0.000 |
Why?
|